Abstract
The deregulation of the marketing of dietary supplements with health claims has increased interest in evaluating the clinical effectiveness of these products. Clinical trials of herbal treatments pose challenges of limited preclinical data, lack of product standardization and characterization, and difficulties of blinding, which are substantially different from those in studies of conventional medications. These issues must be recognized and addressed if studies of herbal remedies are to provide useful information.
Get full access to this article
View all access options for this article.
